Novo Nordisk Looks Beyond Weight Loss to Longevity and Aesthetics
The Business of Fashion
June 8, 2026
Novo's blockbuster drugs could pull it into buzzier areas of healthcare, chief executive Mike Doustdar said, as the Ozempic maker seeks to lessen its reliance on obesity and diabetes.
Discussion in the ATmosphere